NGM BIOPHARMACEUTICALS INC: common_shares_outstanding
| Value | {"unit": "shares", "value": 82907000, "concept": "us-gaap:CommonStockSharesOutstanding"} |
|---|---|
| Period | (as of 2023-12-31) |
| Status | current |
| Entity | NGM BIOPHARMACEUTICALS INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:00:56.671043+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/b79b19f5-e207-4959-88d4-d9e30ac4d308
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-24-010232 · Open the official SEC filing →Retrieved: 2026-08-19T14:00:56.671043+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001426332/common-shares-outstanding/2023-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/b79b19f5-e207-4959-88d4-d9e30ac4d308
History
- no predecessors — first report